Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.26.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Deferred tax assets        
Net operating loss carry-forward $ 101,931 $ 90,177    
Stock-based compensation 5,774 5,698    
Accrued compensation 3,673 172    
Capitalized research and experimentation expenses 0 3,114    
Disallowed interest expense 27,326 15,963    
Other 634 471    
Total deferred tax assets 139,338 115,595    
Valuation allowance (106,992) (85,403) $ (55,852) $ (26,842)
Deferred tax assets, net of valuation allowance 32,346 30,192    
Deferred tax liabilities        
Depreciation and amortization (1,280) (1,310)    
Capitalized research and experimentation expenses (8,151) 0    
Intangibles and goodwill (38,733) (45,190)    
Total deferred tax liabilities (48,164) (46,500)    
Deferred Tax Liabilities, Net $ (15,818) $ (16,308)